BlackRock Fund Advisors’s Biolase, Inc. BIOL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | $146K | Hold |
8
| – | – | ﹤0.01% | 3510 |
|
2016
Q3 | $176K | Hold |
8
| – | – | ﹤0.01% | 3489 |
|
2016
Q2 | $118K | Hold |
8
| – | – | ﹤0.01% | 3622 |
|
2016
Q1 | $134K | Sell |
8
-1
| -11% | -$16.8K | ﹤0.01% | 3587 |
|
2015
Q4 | $92K | Buy |
9
+1
| +13% | +$10.2K | ﹤0.01% | 3750 |
|
2015
Q3 | $94K | Sell |
8
-1
| -11% | -$11.8K | ﹤0.01% | 3719 |
|
2015
Q2 | $187K | Buy |
9
+1
| +13% | +$20.8K | ﹤0.01% | 3551 |
|
2015
Q1 | $191K | Hold |
8
| – | – | ﹤0.01% | 3502 |
|
2014
Q4 | $265K | Buy |
8
+1
| +14% | +$33.1K | ﹤0.01% | 3403 |
|
2014
Q3 | $233K | Sell |
7
-1
| -13% | -$33.3K | ﹤0.01% | 3425 |
|
2014
Q2 | $221K | Sell |
8
-71
| -90% | -$1.96M | ﹤0.01% | 3459 |
|
2014
Q1 | $2.38M | Buy |
79
+4
| +5% | +$120K | ﹤0.01% | 3121 |
|
2013
Q4 | $2.62M | Buy |
75
+2
| +3% | +$69.9K | ﹤0.01% | 3096 |
|
2013
Q3 | $1.73M | Buy |
73
+8
| +12% | +$189K | ﹤0.01% | 3142 |
|
2013
Q2 | $2.85M | Buy |
+65
| New | +$2.85M | ﹤0.01% | 3015 |
|